Development of a novel estimation method for hemoglobin A1c using glycated albumin in type 2 diabetes mellitus patients with end-stage renal disease
- 18 January 2018
- journal article
- research article
- Published by Springer Nature in Diabetology International
- Vol. 9 (3) , 179-188
Abstract
We developed a novel estimation method for hemoglobin A1c (HbA1c) in type 2 diabetes (T2D) patients with end-stage renal disease (ESRD). This method is based on the glycated albumin (GA) level.Keywords
This publication has 25 references indexed in Scilit:
- Assessment of Glycemic Control in Dialysis Patients with DiabetesClinical Journal of the American Society of Nephrology, 2011
- Effects of Thyroid Hormone on A1C and Glycated Albumin Levels in Nondiabetic Subjects With Overt HypothyroidismDiabetes Care, 2010
- 2008 Japanese Society for Dialysis Therapy: Guidelines for Renal Anemia in Chronic Kidney DiseaseTherapeutic Apheresis and Dialysis, 2010
- Glycated Albumin and Glycated Hemoglobin Are Influenced Differently by Endogenous Insulin Secretion in Patients With Type 2 DiabetesDiabetes Care, 2009
- Assessing Glycemic Control in Maintenance Hemodialysis Patients With Type 2 DiabetesDiabetes Care, 2009
- Revised Equations for Estimated GFR From Serum Creatinine in JapanAmerican Journal of Kidney Diseases, 2009
- Oxidative Stress and Inflammation Are Associated with Adiposity in Moderate to Severe CKDJournal of the American Society of Nephrology, 2008
- Association Between Serum Bioavailable Testosterone Concentration and the Ratio of Glycated Albumin to Glycated Hemoglobin in Men With Type 2 DiabetesDiabetes Care, 2008
- Glycated Albumin Is a Better Glycemic Indicator than Glycated Hemoglobin Values in Hemodialysis Patients with DiabetesJournal of the American Society of Nephrology, 2007
- Report of the Expert Committee on the Diagnosis and Classification of Diabetes MellitusDiabetes Care, 2003